Communication With Patients With Vitiligo
Iltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
JAK Inhibitors for the Treatment of Vitiligo
Seemal R. Desai, MD, examines the mechanisms of JAK inhibitors and why these agents play an important role in the treatment of vitiligo.
Vitiligo Treatment Overview
Pearl E. Grimes, MD, discusses intervention strategies for vitiligo, including stabilization, repigmentation, and maintenance. She also explores factors that impact therapeutic outcomes.
Vitiligo Prevalence and Patient Burden
John E. Harris, MD, PhD, reviews factors that shape prevalence of vitiligo and also explores the impact of vitiligo on patient quality of life.
2 Clarke Drive Cranbury, NJ 08512